共 14 条
AN OPEN-LABEL, TOLERABILITY AND EFFICACY STUDY OF ZYN002 (CANNABIDIOL) Administered As A Transdermal Gel To Children And Adolescents With 22Q11.2 Deletion Syndrome (INSPIRE)
被引:0
|作者:
Heussler, H.
[1
]
Cohen, J.
[2
]
Buchanan, C.
[3
]
O'Neill, C.
[4
]
Sebree, T.
[4
]
O'Quinn, S.
[4
]
机构:
[1] Childrens Hlth Queensland Hosp & Hlth Serv, Ctr Clin Trials Rare Neurodev Disorders, South Brisbane, Qld, Australia
[2] Genet Clin Australia, North Caulfield, Vic, Australia
[3] Greenwood Genet Ctr, Greenville, SC USA
[4] Zynerba Pharmaceut, Devon, PA USA
关键词:
22q.11.2;
Anxiety;
Cannabidiol;
Deletion syndrome;
Irritability;
D O I:
暂无
中图分类号:
G76 [特殊教育];
学科分类号:
040109 ;
摘要:
引用
收藏
页码:672 / 672
页数:1
相关论文